Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05130593 · ClinicalTrials.gov registry record
Pilot Study Evaluating the Acceptability and Absorption of the Bioactive Compounds of a Russian Tarragon Nutrasorb Bar
A clinical trial, sponsored by Pennington Biomedical Research Center.
- Completed
- Registry status
- 20
- Enrollment target
NCT05130593 is a clinical trial that has completed, run by Pennington Biomedical Research Center. The registered enrollment target is 20 participants.
The verdict
NCT05130593 has completed, sponsored by Pennington Biomedical Research Center.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
The purpose of this study is to make a bar from the soy-protein Russian Tarragon complex (PMI-5011/Nutrasorb) that is safe and acceptable for consumption, and to test the blood levels of plasma bioactive (DMC-2) after ingestion of the bar. The PMI-5011/Nutrasorb comes from a plant source called Artemisia dracunculus. This plant has a long history of medicinal (health) and culinary (food) use and has been reported as effective as a traditional treatment for diabetes in various parts of the world.
Interventions
- DIETARY_SUPPLEMENT Nutrasorb bar
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2021-10-25 |
| Est. Completion | 2022-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05130593
The ClinicalTrials.gov registry entry for NCT05130593 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Pennington Biomedical Research Center, which has 258 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nutrasorb bar is the first listed.
NCT05130593 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05130593 about?
NCT05130593 is a clinical study titled "Pilot Study Evaluating the Acceptability and Absorption of the Bioactive Compounds of a Russian Tarragon Nutrasorb Bar". The purpose of this study is to make a bar from the soy-protein Russian Tarragon complex (PMI-5011/Nutrasorb) that is safe and acceptable for consumption, and to test the blood levels of plasma bioactive (DMC-2) after ingestion of the bar. The PMI-5011/Nutrasorb comes from a plant source called Arte...
What is the current status of trial NCT05130593?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2021-10-25. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT05130593?
The interventions under investigation include: Nutrasorb bar (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT05130593?
This trial is sponsored by Pennington Biomedical Research Center, which has 258 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.